Tinea

Background

  • Fungal infection caused by dermatophytes that feed on keratin

Tinea Types

Tinea Corporis
Tinea Capitis

Clinical Features

Differential Diagnosis

Evaluation

Management

Coverage for Trichophyton and Epidermophyton and all treatment should be at lease 1 week past resolution of lesions

Topical Therapy

Applies to Tinea corporis, pedis, cruris, and manus

Must use a topical therapy for 7-10days beyond resolution of lesions

Capitis

  • Griseofulvin 500mg-1000mg PO once daily (20-25mg/kg/d)
    • Usually requires 8wk of treatment
  • Terbinafine for 2-4 weeks is as effective of 6-8 weeks of griseofulvin[1]
    • 62.5mg/day in children <20kg
    • 125mg/day in children 20-40kg
    • 250mg/day in children >40kg[2]
  • Selenium sulfide or ketoconazole shampoos are adjunct treatment
  • Children can return to school during treatment

Kerion

  • Oral griseofulvin, itraconazole, or terbinafine for 6-8 wks[3]
  • Cephalexin 40mg/kg/d in 4 divided doses in addition to systemic antifungal treatment if there is evidence or high risk of bacterial secondary infection
  • Ketoconazole shampoo, isolated towels decrease spread to household members

Tinea corporis

First line should be topical therapy. For refractory cases or severe bullous disease the below anti-fungals are all equivalent options.

Disposition

  • Discharge

See Also

References

  1. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114(5):1312-1315. doi:10.1542/peds.2004-0428
  2. Andrews MD, Burns M: Common tinea infections in children. Am Fam Physician 2008;77(10):1415-1420.
  3. Gnanasegaram M. Kerion. DermNet NZ. 2012. http://www.dermnetnz.org/fungal/kerion.html